Skip to main content
. 2022 May 24;49(11):3651–3667. doi: 10.1007/s00259-022-05842-5

Fig. 6.

Fig. 6

Efficacy of 177Lu-FAP-2286 treatment in the Sarc4809 tumor model. Sarc4809 tumor-bearing mice were treated with vehicle, natLu-FAP-2286, or 177Lu-FAP-2286 at 30 or 60 MBq (n = 10 mice/group). Mean relative tumor volumes ± SEM (A), mean body weight change ± SEM (B), and a summary table (C) are shown